MA S2220 | 2017-2018 | 190th General Court

Note: Legislation replaced by S2202

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on November 9 2017 - 25% progression
Action: 2017-11-09 - See S2202
Text: Latest bill text (Introduced) [PDF]

Summary

Transparency in Prescription Drug Formularies:

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Transparency in Prescription Drug Formularies:

Sponsors


History

DateChamberAction
2017-11-09SenateSee S2202

Same As/Similar To

S2202 (Replaced by) 2017-11-09 - Reprinted as amended, see S2211
H331 (Similar To) 2017-07-05 - Hearing scheduled for 07/11/2017 from 10:00 AM-01:00 PM in A-2
S1757 (Similar To) 2017-10-11 - Hearing scheduled for 10/16/2017 from 01:00 PM-05:00 PM in B-1
S365 (Similar To) 2017-08-23 - Hearing scheduled for 09/06/2017 from 01:00 PM-03:00 PM in B-1
S1638 (Similar To) 2017-10-24 - Hearing canceled – new hearing TBD
H166 (Similar To) 2017-09-20 - Hearing scheduled for 10/03/2017 from 01:00 PM-04:00 PM in A-1
H4112 (Similar To) 2018-01-16 - Senate concurred
H4113 (Similar To) 2018-01-16 - Senate concurred

Massachusetts State Sources


Bill Comments

feedback